Rising stomach disorders ramp up Australia’s upper endoscopy market | Health Care Asia Magazine

Rising stomach disorders ramp up Australia’s upper endoscopy market

Flexible video gastroscopes accounted for over 90% of the market.

Driven by growing demand due to the high prevalence of gastrointestinal disorders, the esophagoscopes and gastroscopes market in Australia is expected to witness a compound annual growth rate of 14% through 2025, according to a GlobalData report.

Also contributing to the growth is rising government support for the healthcare sector, as well as higher incomes, said GlobalData’s medical devices analyst, Vedant Goswami. Endoscopes using advanced technologies and integrated systems also now dominate the market.

Flexible video gastroscopes accounted for more than 90% of the esophagoscopes and gastroscopes market in Australia in 2020. Their popularity, compared to traditional scopes, was attributed to their ease of use, patient safety, and advanced resolution images.

“The number of flexible video gastroscopes installed in healthcare facilities will continue to grow steadily due to the increasing number of patients suffering from gastrointestinal diseases and demand for minimally invasive procedures,” Goswami added.

Patients with conditions such as gastroesophageal reflux disease or GERD, stomach and oesophageal cancer, and peptic ulcers, constitute most individuals that require the use of esophagoscopes and gastroscopes.

Get Health Care Asia Magazine in your inbox
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The majority of the country’s pharma manufacturing produces generic drugs.
This is expected to affect local pharma growth in the short term.
Nonetheless, more than half of the age group found its use to be comfortable.
The group’s profits after tax ballooned by as much as 138.4%.
Funds will be used to build out its behavioural health and chronic care modules.
Some players have been highly active in digital channels of various countries.
It has also formed a JV with Acurio to develop a private hospital in NSW.
With this, the company now offers an all-in-one patient management service.
The therapy can be done in eight different languages.
The country is expected to have one in five of its population to be elderly by 2050.
Sunway is planning to ramp up its hospital capacity to about 3,000 beds.
The system will help city managers to track epidemic conditions, real-time.
It is funded through the 2020 Primary Healthcare Research Data Infrastructure grants.
The hospital features 200 general inpatient beds and 100 hemodialysis beds.
The platform expanded its services after obtaining an internet hospital license.